Russian President Vladimir Putin has signed a federal law that authorizes the government to make decisions, under international agreements, on the use of an invention for the production of a medicinal product in Russia for export purposes without the consent of the patent owner. The document is published on publication.pravo.gov.ru, the official portal of legal information.
According to the law No. 212-FZ of 11.06.2021, the patent owner will receive notification of the use of their invention as soon as possible, as well as subsequent proportionate compensation.
After taking a decision on such use, the Cabinet of Ministers will have to specify the volume of production of the medicinal product necessary for the needs of a foreign state to which the product will be supplied. In this case, the packaging of the manufactured drug will feature a special sign.
The document also gives the Cabinet of Ministers the right to approve the procedure for sending a notification, the basis and the procedure for making a decision on the production of a medicinal product to be exported.
